Meyka Pro banner
Hitek Global Inc.

Stay Updated with the Latest Hitek Global Inc. HKIT News in Real Time

Find HKIT news now at Meyka AI. Stay informed with the latest Hitek Global Inc. stocks updates, including price news, market analysis, and expert insights.

HKITNASDAQ
TechnologyInformation Technology Services
$3.10
$0.15(5.08%)
U.S. Market opens in 5h 10m
IT Stocks Rally: NIFTY IT Jumps 3% as TCS Gains 3.6%, Infosys 2.8% on Salesforce Boost
📅 in about 5 hours

IT Stocks Rally: NIFTY IT Jumps 3% as TCS Gains 3.6%, Infosys 2.8% on Salesforce Boost

IT stocks staged a sharp rally on August 28, 2026, pushing the NIFTY IT index up around 3%. TCS shares gained 3.6%, while Infosys rose 2.8% as strong global technology cues lifted investor sentiment. The move came after strong results from Salesforce and Nvidia, which renewed optimism around software, AI and enterprise technology spending. The…

Read more 12
SK Gas Tanker Pays Record $5.3 Million for Priority Transit Through Panama Canal
📅 in about 4 hours

SK Gas Tanker Pays Record $5.3 Million for Priority Transit Through Panama Canal

SK Gas paid a record $5.3 million to secure priority passage through the Panama Canal, the waterway’s deputy administrator confirmed Thursday, August 27, 2026. The South Korean company won the auction for its G. Spirit LPG tanker to transit northbound on September 1. This fee breaks the previous record of $4.6 million, set just two…

Read more 12
Indian Stock Market Today: SENSEX Jumps 350 Points, NIFTY50 Above 24,150 as IT Stocks Rally
📅 in about 3 hours

Indian Stock Market Today: SENSEX Jumps 350 Points, NIFTY50 Above 24,150 as IT Stocks Rally

Indian stock market indices extended gains through Friday morning, August 28, 2026, led by a sharp IT sector rally. The Sensex climbed roughly 366 points, or 0.47%, to near 77,295. The Nifty50 pushed past 24,168, building on its early gains. Nifty IT rose over 1% as traders awaited Fed Chair Kevin Warsh’s Jackson Hole remarks….

Read more 12
ESDS Software Solution IPO Opens August 28: GMP Signals 76% Listing Gain, Key Details
📅 in about 3 hours

ESDS Software Solution IPO Opens August 28: GMP Signals 76% Listing Gain, Key Details

The ESDS Software Solution IPO opened for subscription on August 28, 2026, with a ₹720 crore issue and a price band of ₹408 to ₹429 per share. The offering has drawn early attention after its grey market premium of around ₹325 suggested a potential 76% listing gain. Strong anchor investor participation has added to the…

Read more 12
Yamaha R2 Launches in India at ₹2.30 Lakh on August 27
📅 in about 1 hour

Yamaha R2 Launches in India at ₹2.30 Lakh on August 27

Yamaha launches YZF-R2 in India at ₹2.30 lakh with 204cc engine, 26.5 PS power, and three variants. Deliveries begin mid-September 2026. Competes with KTM RC 200.

Read more 12
John Howard Vindicated on Border Control as Migration Crisis Tests Australia Again
📅 7 hours ago

John Howard Vindicated on Border Control as Migration Crisis Tests Australia Again

25 years after the Tampa affair, John Howard’s border control legacy is under fresh scrutiny as Australia grapples with renewed migration challenges and policy debates.

Read more 12
Nvidia Guides 70% Growth for Fiscal 2028 After Q2 Revenue Doubles to $96.2B
📅 14 hours ago

Nvidia Guides 70% Growth for Fiscal 2028 After Q2 Revenue Doubles to $96.2B

Nvidia beats Q2 earnings with $96.2B revenue, up 106% YoY. CEO Jensen Huang forecasts 70% fiscal 2028 growth, far exceeding analyst consensus. Data center revenue surges 117% as AI demand accelerates.

Read more 12
US and China Race for Pacific Deep-Sea Mining as Australia Faces Pressure to Act
📅 14 hours ago

US and China Race for Pacific Deep-Sea Mining as Australia Faces Pressure to Act

US and China compete for Pacific deep-sea mining of critical minerals worth USD 30 trillion. Australia faces pressure to shape international governance before operations start in 2027.

Read more 12
AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial
📅 15 hours ago

AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial

AstraZeneca said Thursday its drug Tezspire met all primary and secondary goals in a late-stage trial. The Phase III CROSSING trial tested Tezspire against placebo in eosinophilic oesophagitis (EoE). AstraZeneca developed the drug jointly with Amgen for this chronic inflammatory oesophagus condition. What the CROSSING Trial Showed The Phase III CROSSING trial evaluated two once-every-four-week…

Read more 12

HKIT News FAQ